National and Kapodistrian University of Athens
Μελέτη προγνωστικών και διαγνωστικών δεικτών οξείας νεφρικής βλάβης σε ασθενείς που υποβάλλονται σε αγγειοχειρουργικές επεμβάσεις κοιλιακής αορτής
Abstract
dc:descriptionAcute Kidney Injury (AKI) represents a serious and well-recognized complication for both open and endovascular aneurysm repair and has a major impact on these patients’ morbidity and mortality. Early diagnosis of AKI could assist in a more-effective care of these patients. AKI has traditionally been defined by measuring surrogates of kidney-filtration function, such as serum creatinine (sCr) and urine output.There is still no broadly accepted consensus on the degree of sCr elevation required to qualify for the diagnosis of AKI. The AKIN classification is a new system for staging and classifying AKI. The parameters used to define AKI according AKIN classification are the absolute increase of serum creatinine levels greater than 0,3 mg /dL, the percentage increase of serum creatinine levels of greater than 50% or the decrease of urine output less than 0,5 mg/kg/h for 6 hours.Despite recent advances in the understanding of the pathophysiologic events leading to AKI, the therapeutic interventions for AKI are ineffective as long as there is no specific renal biomarker to allow the early diagnosis of AKI. Delay in the diagnosis of AKI using conventional biomarkers like serum creatinine has been one of the most important disadvantages in applying efficient treatment of AKI. Serum creatinine represents an insensitive and unreliable biomarker during acute changes of renal function. Serum creatinine concentration does not reflect tubular function or injury, which many kidney injury biomarkers identify. New biomarkers are likely to be important in establishing early diagnosis and guiding more effective therapeutic measures in patients in whom kidney function has not been permanently affected after abdominal aneurysm repair. Recent research has focused on biomarkers of AKI, which have the potential to set the diagnosis earlier. Several biomarkers have been detected in urine. The current literature considers them as early, noninvasive, and sensitive indicators of AKI. Cystatin C (CysC), Neutrophil Gelatinase Associated Lipocalin (NGAL) and B-2 Microglobulin have been investigated as biomarkers of AKI in several conditions as ICU, sepsis, contrast induced nephropathy and in several operations as cardiopulmonary bypass .AimThe aim of this study was to determine the accuracy of these biomarkers as a method of early prediction and detection for AKI among patients with abdominal aortic aneurysm treated through an open or endovascular approach.Materials and MethodsA total of 126 consecutive patients with infrarenal AAA were prospectively enrolled from September 2009 to January 2011. Eighty seven patients (69%) underwent elective endovascular repair (EVAR) and 39 patients (31%) underwent an elective open repair (OR). All patients were treated by the same group of vascular surgeons working at a single institution . In the OR group, none of the patients required suprarenal cross clamp. Twenty-two patients required a bifurcated Dacron graft and in 17 patients a tube Dacron graft was inserted. With regard to the EVAR group, 71 patients treated with supra-renal fixation devices and 16 patients with infra-renal fixation devices. Non-ionic, isoosmolar radiocontrast agent was administered in all EVAR patients and its volume was recorded. None of the 87 patients had occlusion of a renal artery intraoperatively and none of them required an early CTA during their hospital stay.Preoperative patient characteristics were collected and recorded. Data included age, gender, current or previous history of tobacco use, diabetes mellitus, hypertension and a history of coronary artery disease. Significant intraoperative risk factors and peri- and post-operative complications were recorded as well. All therapeutic and clinical care decisions were made by the vascular surgeons. Additional infusion of crystalloid liquids and diuretics were administered in order to maintain a adequate diuresis if needed. The decision to initiate renal replacement therapy (RRT) or to make other renal interventions was made by the consulting nephrologists.The primary end point of this prospective cohort study was the development of postoperative AKI, as defined by the AKIN criteria: Patients with AKIN 1 stage had an absolute increase in sCr above baseline of at least 0.3 mg/dL, or a percentage increase of at least 50% within 48 hours of operation or urine output was less from 0,5 ml/kg/hr for 6 hours. AKIN 2 stage refers to a percentage increase of at least 100% within 48 hours of operation or urine output less than 0,5 ml/kg/hr for 12 hours. AKIN 3 stage is defined as a percentage increase of at least 200% or Cr ≥ 4mg/dL (with acute rise of 0,5 mg/dL), or urine output less than 0,3 ml/kg/hr for 24 hours or anouria with duration more than 12 hours. In the study,sCr changes have been used for AKI diagnosis as urine output may be influenced by hydration or diuretics agents. Secondary end points were the duration and severity of AKI, the progression of eGFR (estimated Glomerular Filtration Rate), the hospital length of stay, the need for Renal Replacement Therapy and the in-hospital mortality.Blood samples and spot urine samples were collected simultaneously before surgery (baseline) and postoperatively at 6, 24 and 48 hours thereafter. A final collection was made on day 5. The biomarkers under investigation were measured with various techniques and protocols in the hospital's laboratory.ResultsIn total 126 subjects consented for the study and all completed the protocol . At baseline, patients that developed AKI were significantly older than those who did not develop AKI.Diabetes was more frequent in patients who subsequently developed AKI than in those who did not, as was chronic kidney disease defined as eGFR <60 ml/min. However there was no significant difference in the prevalence of dyslipidemia, coronary artery disease and heart failure between the two patients groups. The mean(± SD) contrast volume in the AKI group did not differ significantly from those who did not developed AKI. However, the AKI population had significantly higher baseline levels of sCr, uCysC and had lower eGFR calculated with the MDRD equation. Moreover they had significantly larger aneurysms in diameter, stayed longer time in the operating room and subsequently were more likely to enter the ICU and finally stayed longer time in the hospital.Acute Kidney Injury (AKI) was more frequent among the patients undergoing OR. Fifteen of the 87 patients in the EVAR group while 13 of the 39 patients in the OR group (33%) developed AKI.Patients who developed AKI in both groups had significantly higher sCysC,uB-2 Microglobulin , uCys and uNGAL concentrations at 6 hours postoperatively compared with patients who did not develop postoperative AKI. Urinary CysC and urinary NGAL values were the best biomarkers in accuracy compared to urinary B2-Microglobulin and serum Cystatin C. These biomarkers continued to increase at 24 hours and peaked at 48 hours while no increase was observed among those who did not develop AKI at 6 hours and at 24 respectively. Same analysis for sCr shows significant increase in AKI patients at 24 hours postoperatively. The diagnostic accuracy of uCysC and uNGAL at 6 hours post-surgery was excellent (AUC-ROC=0.968 and 0.986 respectively), significantly higher than sCr (AUC-ROC=0.844).ConclusionsIn this prospective clinical study, the assessment of various biomarkers as serum Cystatin, urinary Cystatin, b-2 microglobulin and urinary NGAL even at 6 hours post the Open or Endovascular AAA repair can predict with increased sensitivity and specificity a consequent renal dysfunction which will be clinically obvious the next 24 or 48 hours. ACR Ratio is an important biomarker as the baseline levels could stratify patients at high or low risk for acute kidney injury postoperatively. This piece of information can be proved valuable for the treating physician as a variety of measures to treat the upcoming renal failure can be undertaken in advance, ameliorating the potentially devastating complication. To our knowledge, this is the first study evaluating the potential role of these biomarkers for early recognition of Acute Kidney injury after open and endovascular abdominal aortic aneurysm repair. Future studies are needed to validate these findings and confirm new ways to intervene in a “kidney at risk” in order to reduce the morbidity and mortality associated with AKI after elective abdominal aortic aneurysm repair.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pirgakis, Konstantinos
- Πυργάκης, Κωνσταντίνος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42859